Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Long-Term Debt Issuances (2020 - 2025)

Updated

Elicio Therapeutics (ELTX) posted Long-Term Debt Issuances of $9.87 million for FY2025, down 50.0% from $19.73 million in FY2024.

Analysis

Elicio Therapeutics (ELTX) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

Since FY2020, Elicio Therapeutics has reported Long-Term Debt Issuances for 4 years.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of -20.6% (FY2020 to FY2025).
  • Business Quant data shows ELTX's Long-Term Debt Issuances at $19.73 million in FY2024 (+97.3%) and $10 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Elicio Therapeutics 42.49 Mn -35.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 9.87 Mn
Mar 31, 2025 9.14 Mn
Sep 30, 2024 19.73 Mn
Mar 31, 2023 10.00 Mn
Dec 31, 2021 302,000.00
Sep 30, 2020 17.29 Mn
Jun 30, 2020 11.78 Mn
Mar 31, 2020 3.05 Mn
API Access

Elicio Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ELTX&period=max&api_key=YOUR_API_KEY